AptarGroup Inc (ATR)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$98.00

Buy

$122.94

arrow-up$3.46 (+2.93%)

Prices updated at 12 Dec 2025, 21:10 EST

Prices minimum 15 mins delay

Prices in USD

AptarGroup, Inc. is a solution provider of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Ms. Candace S. Matthews

CEO

Mr. Stephan B. Tanda

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

13,500

Head office

265 Exchange Drive

Crystal Lake

United States

60014

+1 815 477-0424

matt.dellamaria@aptar.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. George L. Fotiades Independent Director	0.11m
Mr. Ralf K. Wunderlich Independent Director	0.11m
Ms. Isabel Marey-Semper Independent Director	0.11m
Ms. Giovanna Kampouri Monnas Independent Director	0.12m
Mr. Stephan B. Tanda Director, President and Chief Executive Officer	1.18m
Mr. Matthew L. Trerotola Independent Director	0.12m
Mr. Gael Touya President, Aptar Pharma	0.60m
Ms. Candace S. Matthews Chairman of the Board	0.21m
Mr. B. Craig Owens Independent Director	0.14m
Ms. Sarah Glickman Independent Director	0.11m
Mr. Marc Prieur President, Aptar Beauty	0.66m
Ms. Xiangwei Gong Executive Vice President, Strategic Group Development Beyond the Current Segments and President, Aptar Asia	0.52m
Ms. Shiela Vinczeller Chief Human Resources Officer	-
Mr. Hedi Tlili President, Aptar Closures	0.58m
Ms. Kimberly Y. Chainey Executive Vice President, Chief Legal Officer and Corporate Secretary	-
Ms. Vanessa Kanu Executive Vice President and Chief Financial Officer	-
Ms. Julie Xing Independent Director	0.11m
Mr. Daniel Ackerman Senior Vice President and Chief Accounting Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	7,079,648
BlackRock Inc	6,249,898
State Farm Mutual Automobile Ins Co	4,744,564
Morgan Stanley - Brokerage Accounts	4,251,697
BlackRock Fund Advisors	3,370,849

Director dealings

Date chevron-l-regular chevron-r-regular	Action
22 Nov 2024	-
15 Nov 2024	-
12 Nov 2024	-
12 Nov 2024	-
12 Nov 2024	-
01 Nov 2024	-
29 Oct 2024	-
28 Oct 2024	-
28 Oct 2024	-
28 Oct 2024	-
28 Oct 2024	-
28 Oct 2024	-
13 Sep 2024	-
09 Sep 2024	-
29 Aug 2024	-
29 Aug 2024	-
29 Aug 2024	-
26 Aug 2024	-
26 Aug 2024	-
26 Aug 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.